Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

1.

Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial.

Ocean AJ, Pennington KL, Guarino MJ, Sheikh A, Bekaii-Saab T, Serafini AN, Lee D, Sung MW, Gulec SA, Goldsmith SJ, Manzone T, Holt M, O'Neil BH, Hall N, Montero AJ, Kauh J, Gold DV, Horne H, Wegener WA, Goldenberg DM.

Cancer. 2012 Nov 15;118(22):5497-506. doi: 10.1002/cncr.27592. Epub 2012 May 8.

PMID:
22569804
[PubMed - indexed for MEDLINE]
Free Article
2.

Treatment of advanced pancreatic carcinoma with 90Y-Clivatuzumab Tetraxetan: a phase I single-dose escalation trial.

Gulec SA, Cohen SJ, Pennington KL, Zuckier LS, Hauke RJ, Horne H, Wegener WA, Teoh N, Gold DV, Sharkey RM, Goldenberg DM.

Clin Cancer Res. 2011 Jun 15;17(12):4091-100. doi: 10.1158/1078-0432.CCR-10-2579. Epub 2011 Apr 28.

PMID:
21527562
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft.

Gold DV, Modrak DE, Schutsky K, Cardillo TM.

Int J Cancer. 2004 Apr 20;109(4):618-26.

PMID:
14991585
[PubMed - indexed for MEDLINE]
4.

Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabine.

Karacay H, Sharkey RM, Gold DV, Ragland DR, McBride WJ, Rossi EA, Chang CH, Goldenberg DM.

J Nucl Med. 2009 Dec;50(12):2008-16. doi: 10.2967/jnumed.109.067686.

PMID:
19949026
[PubMed - indexed for MEDLINE]
Free Article
5.
6.

Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer.

Joensuu TK, Kiviluoto T, Kärkkäinen P, Vento P, Kivisaari L, Tenhunen M, Westberg R, Elomaa I.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):444-52.

PMID:
15380578
[PubMed - indexed for MEDLINE]
7.

Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer.

Gold DV, Schutsky K, Modrak D, Cardillo TM.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3929S-37S.

PMID:
14506191
[PubMed - indexed for MEDLINE]
Free Article
8.

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer.

Blackstock AW, Bernard SA, Richards F, Eagle KS, Case LD, Poole ME, Savage PD, Tepper JE.

J Clin Oncol. 1999 Jul;17(7):2208-12.

PMID:
10561277
[PubMed - indexed for MEDLINE]
Free Article
9.

A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer.

Martenson JA, Vigliotti AP, Pitot HC, Geeraerts LH, Sargent DJ, Haddock MG, Ghosh C, Keppen MD, Fitch TR, Goldberg RM.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1305-10.

PMID:
12654442
[PubMed - indexed for MEDLINE]
10.

Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer.

Shibuya K, Oya N, Fujii T, Doi R, Nakamura A, Matsuo Y, Mitsumori M, Hiraoka M.

Am J Clin Oncol. 2011 Apr;34(2):115-9. doi: 10.1097/COC.0b013e3181c4c7a8.

PMID:
20065850
[PubMed - indexed for MEDLINE]
11.

Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial.

Girard N, Mornex F, Bossard N, Ychou M, Chauffert B, Wautot V.

Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1426-32. doi: 10.1016/j.ijrobp.2009.06.053. Epub 2010 Jan 7.

PMID:
20056351
[PubMed - indexed for MEDLINE]
12.

A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.

Duffy A, Kortmansky J, Schwartz GK, Capanu M, Puleio S, Minsky B, Saltz L, Kelsen DP, O'Reilly EM.

Ann Oncol. 2008 Jan;19(1):86-91. Epub 2007 Sep 17.

PMID:
17878176
[PubMed - indexed for MEDLINE]
Free Article
13.

Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer.

Yavuz AA, Aydin F, Yavuz MN, Ilis E, Ozdemir F.

Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):974-81.

PMID:
11704320
[PubMed - indexed for MEDLINE]
14.

Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.

Forero A, Meredith RF, Khazaeli MB, Shen S, Grizzle WE, Carey D, Busby E, LoBuglio AF, Robert F.

Cancer Biother Radiopharm. 2005 Oct;20(5):467-78.

PMID:
16248762
[PubMed - indexed for MEDLINE]
15.

A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.

Ikeda M, Okada S, Tokuuye K, Ueno H, Okusaka T.

Br J Cancer. 2002 May 20;86(10):1551-4.

PMID:
12085203
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

High rates of durable responses with anti-CD22 fractionated radioimmunotherapy: results of a multicenter, phase I/II study in non-Hodgkin's lymphoma.

Morschhauser F, Kraeber-Bodéré F, Wegener WA, Harousseau JL, Petillon MO, Huglo D, Trümper LH, Meller J, Pfreundschuh M, Kirsch CM, Naumann R, Kropp J, Horne H, Teoh N, Le Gouill S, Bodet-Milin C, Chatal JF, Goldenberg DM.

J Clin Oncol. 2010 Aug 10;28(23):3709-16. doi: 10.1200/JCO.2009.27.7863. Epub 2010 Jul 12.

PMID:
20625137
[PubMed - indexed for MEDLINE]
Free Article
17.

A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.

Wong JY, Shibata S, Williams LE, Kwok CS, Liu A, Chu DZ, Yamauchi DM, Wilczynski S, Ikle DN, Wu AM, Yazaki PJ, Shively JE, Doroshow JH, Raubitschek AA.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5842-52. Review.

PMID:
14676105
[PubMed - indexed for MEDLINE]
Free Article
18.

Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer.

Epelbaum R, Rosenblatt E, Nasrallah S, Faraggi D, Gaitini D, Mizrahi S, Kuten A.

J Surg Oncol. 2002 Nov;81(3):138-43.

PMID:
12407726
[PubMed - indexed for MEDLINE]
19.

Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.

Brade A, Brierley J, Oza A, Gallinger S, Cummings B, Maclean M, Pond GR, Hedley D, Wong S, Townsley C, Brezden-Masley C, Moore M.

Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1027-36. Epub 2006 Dec 29.

PMID:
17197132
[PubMed - indexed for MEDLINE]
20.

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

McGinn CJ, Zalupski MM, Shureiqi I, Robertson JM, Eckhauser FE, Smith DC, Brown D, Hejna G, Strawderman M, Normolle D, Lawrence TS.

J Clin Oncol. 2001 Nov 15;19(22):4202-8.

PMID:
11709563
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk